March 10, 2025

Ozempic’s New Frontier: The War on Aging

Recent research indicates that GLP-1 drugs like Ozempic, initially approved for diabetes and weight loss, may offer additional health benefits. These include potential protective effects against age-related conditions such as Alzheimer’s disease, osteoarthritis, certain cancers, and overall mortality.

To read full article, visit: Ozempic’s New Frontier: The War on Aging – WSJ

Our mission is to help clients protect assets and enhance employee outcomes through the delivery of exceptional risk management and employee benefit consulting services and products.

Copyright © 2025 The Fedeli Group Powered by DevQ